logo
Share SHARE
FONT-SIZE Plus   Neg

Onyx Pharma Loss Widens In Q1

Onyx Pharmaceuticals, Inc. (ONXX) Wednesday reported a first-quarter loss of $56.2 million or $0.88 per share, which widened from $49.2 million or $0.78 per share in the same period last year.

Adjusted loss for the period was $43.5 million or $0.68 per share, compared to $14.2 million or $0.23 per share last year.

On average, 12 analysts polled by Thomson Reuters expected a loss of $0.63 per share for the first quarter. Analysts' estimates typically exclude special items.

First-quarter revenues increased 7 percent to $72.0 million from $67.1 million last year. Analysts expected revenues of $70.04 million for the period.

Operating expenses for the period totaled $122.8 million, up from $108.5 million last year.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
The Museum of Failures is set to open in Helsingborg, Sweden in June. The museum will feature a collection of innovation failures that will provide visitors a fascinating learning experience. The museum's collection consists of over sixty epic failed products and services from around the world. Netflix Inc. has finally gained an entry into China's lucrative entertainment market, one of the few markets in the world the online-video streaming service does not have a presence in. Netflix said it has signed a licensing deal with video streaming platform iQiyi, owned by China's biggest search engine Baidu.com. Sergey Brin, Google's co-founder, is said to be secretly building a massive airship inside Hangar 2 at the NASA Ames Research Center, Bloomberg reported, citing people with knowledge of the project. As per the report, the craft looks like a zeppelin-like airship, and its not clear whether its a hobby...
comments powered by Disqus
Follow RTT